𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of antidepressants and risk of lung cancer

✍ Scribed by Sengwee Toh; Luis A. García Rodríguez; Sonia Hernández-Díaz

Publisher
Springer Netherlands
Year
2007
Tongue
English
Weight
213 KB
Volume
18
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antidepressant use and breast cancer ris
Antidepressant use and breast cancer risk
✍ Chloe Chien; Christopher I. Li; Susan R. Heckbert; Kathleen E. Malone; Denise M. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 175 KB
Use of nonaspirin NSAIDs and risk of lun
Use of nonaspirin NSAIDs and risk of lung cancer
✍ Mette Vinther Skriver; Mette Nørgaard; Aslak Harbo Poulsen; Søren Friis; Henrik 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 1 views

## Abstract Epidemiologic evidence is conflicting regarding the potential for nonsteroidal antiinflammatory drugs (NSAIDs) to lower the risk of lung cancer. We thus determined the incidence of lung cancer among a cohort of over 242,000 adults in Denmark who had been issued NSAID prescriptions durin

Colorectal cancer risk in relation to an
Colorectal cancer risk in relation to antidepressant medication use
✍ Jessica Chubak; Denise M. Boudreau; Stephen J. Rulyak; Margaret T. Mandelson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB

## Abstract Laboratory studies suggest that antidepressants affect the risk of some cancers, including colorectal cancer. To investigate whether selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) are associated with colorectal cancer risk, we conducted a case‐contr

Leanness and lung-cancer risk
Leanness and lung-cancer risk
✍ Paul Knekt; Markku Heliövaara; Aila Rissanen; Arpo Aromaa; Ritva Seppänen; Lyly 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 607 KB

Body mass index (weightlheight2) was studied for its prediction of lung cancer in Finnish men examined by the Social Insurance Institution's Mobile Clinic and followed up by the Finnish Cancer Registry. Among 25,994 participants aged 20 to 75 years and free from cancer at the start of the study, 504